Last Updated: November 8, 2026

NUTRESTORE Drug Patent Profile

Name: NUTRESTORE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

When do Nutrestore patents expire, and what generic alternatives are available?

Nutrestore is a drug marketed by Emmaus Medcl and is included in one NDA.

The generic ingredient in NUTRESTORE is l-glutamine. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the l-glutamine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Nutrestore

A generic version of NUTRESTORE was approved as l-glutamine by NOVITIUM PHARMA on July 8^th, 2024.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for NUTRESTORE?
What are the global sales for NUTRESTORE?
What is Average Wholesale Price for NUTRESTORE?

Summary for NUTRESTORE

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	134
Clinical Trials:	11
Patent Applications:	3,977
Drug Prices:	Drug price information for NUTRESTORE
DailyMed Link:	NUTRESTORE at DailyMed

Drug patent expirations by year for NUTRESTORE

Recent Clinical Trials for NUTRESTORE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National Cancer Institute (NCI)	Phase 1
AstraZeneca	Phase 1
M.D. Anderson Cancer Center	Phase 1

See all NUTRESTORE clinical trials

US Patents and Regulatory Information for NUTRESTORE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Emmaus Medcl	NUTRESTORE	l-glutamine	FOR SOLUTION;ORAL	021667-001	Jun 10, 2004		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for NUTRESTORE

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Emmaus Medcl	NUTRESTORE	l-glutamine	FOR SOLUTION;ORAL	021667-001	Jun 10, 2004	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for NUTRESTORE

See the table below for patents covering NUTRESTORE around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Austria	216253		⤷ Start Trial
Australia	2790692		⤷ Start Trial
Australia	661242		⤷ Start Trial
Canada	2120626	METHODE DE STIMULATION DE L'ABSORPTION INTESTINALE (METHOD FOR ENHANCING GUT ABSORPTION)	⤷ Start Trial
Germany	69232561		⤷ Start Trial
Denmark	0607278		⤷ Start Trial
European Patent Office	0607278	PROCEDE PERMETTANT D'AMELIORER L'ABSORPTION INTESTINALE (METHOD FOR ENHANCING GUT ABSORPTION)	⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.